Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLY-AF: Cryoballoon Ablation vs AADs for First-Line AF Treatment
NCT02825979Unknown
- Start
- Jan 2017
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms). Primary endpoint: Time to first recurrence of symptomatic or asymptomatic Atrial Fibrillation, Atrial Flutter or Atrial Tachycardia. Status: unknown.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02825979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02825979.